Stay updated on CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Sign up to get notified when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.
Latest website image capture
Clouds background image

Latest updates to the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T08:58:00.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added 'Gastric cancer' under Conditions and introduced a new Resources link to the Genetic and Rare Diseases Information Center. Removed the older Revision: v3.4.1 entry.
    Difference
    0.2%
    Check dated 2026-02-14T02:00:44.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The revision label updated from v3.4.0 to v3.4.1. This appears to be a version update with no impact on the study details or page content.
    Difference
    0.0%
    Check dated 2026-02-06T17:42:09.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Anticoagulation guidance updated to allow therapeutic LMWH under specified conditions and eligibility/safety criteria revised across GI cancer cohorts; baseline requirements and related notes were updated.
    Difference
    1%
    Check dated 2026-01-23T17:29:21.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4. No visible changes to study details, eligibility criteria, or other core content.
    Difference
    0.0%
    Check dated 2026-01-16T11:53:17.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a dedicated Locations section listing Kansas and Pennsylvania sites and updated the page to revision v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-18T23:26:44.000Z thumbnail image

Stay in the know with updates to CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab

Enter your email address, and we'll notify you when there's something new on the CAMILLA Clinical Trial: Cabozantinib + Durvalumab ± Tremelimumab page.